| 2302371 | Stl22 | Serum triglyceride level QTL 22 | 5.15 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5218294 | 57114705 | Rat |
| 2303585 | Bw86 | Body weight QTL 86 | 4 | | body mass (VT:0001259) | body weight (CMO:0000012) | 4 | 14678065 | 59678065 | Rat |
| 8552903 | Pigfal2 | Plasma insulin-like growth factor 1 level QTL 2 | 7.3 | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 4 | 1 | 31934116 | Rat |
| 724557 | Plsm1 | Polydactyly-luxate syndrome (PLS) morphotypes QTL 1 | | 0.0003 | forelimb integrity trait (VT:0010562) | front foot phalanges count (CMO:0001947) | 4 | 1 | 27716890 | Rat |
| 9590100 | Sffal4 | Serum free fatty acids level QTL 4 | 7.36 | 0.05 | blood free fatty acid amount (VT:0001553) | plasma free fatty acids level (CMO:0000546) | 4 | 1 | 31934116 | Rat |
| 8552906 | Pigfal3 | Plasma insulin-like growth factor 1 level QTL 3 | | | blood insulin-like growth factor amount (VT:0010479) | plasma insulin-like growth factor 1 level (CMO:0001299) | 4 | 10084089 | 55084089 | Rat |
| 1357341 | Gluco5 | Glucose level QTL 5 | 6.4 | | adipocyte free fatty acid secretion trait (VT:0010465) | absolute change in adipocyte free fatty acid secretion per unit volume (CMO:0001446) | 4 | 1 | 33250345 | Rat |
| 1357343 | Gluco4 | Glucose level QTL 4 | | 0.00002 | adipocyte glucose uptake trait (VT:0004185) | adipocyte maximal glucose uptake to basal glucose uptake ratio (CMO:0000874) | 4 | 1 | 33250345 | Rat |
| 6478766 | Anxrr47 | Anxiety related response QTL 47 | | 0.09637 | locomotor behavior trait (VT:0001392) | number of entries into a discrete space in an experimental apparatus (CMO:0000960) | 4 | 10084089 | 55084089 | Rat |
| 631642 | Stl2 | Serum triglyceride level QTL 2 | 3.3 | | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5219178 | 56647776 | Rat |
| 6478769 | Anxrr48 | Anxiety related response QTL 48 | | 0.02514 | locomotor behavior trait (VT:0001392) | amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) | 4 | 10084089 | 55084089 | Rat |
| 631261 | Tcas3 | Tongue tumor susceptibility QTL 3 | 6.88 | | tongue integrity trait (VT:0010553) | number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) | 4 | 10814170 | 91360527 | Rat |
| 61333 | Gluco16 | Glucose level QTL 16 | 4.3 | 0.00001 | adipocyte glucose uptake trait (VT:0004185) | absolute change in adipocyte glucose uptake (CMO:0000873) | 4 | 1 | 30372989 | Rat |
| 634323 | Hc2 | Hypercalciuria QTL 2 | 2.15 | | urine calcium amount (VT:0002985) | urine calcium excretion rate (CMO:0000763) | 4 | 210796 | 45210796 | Rat |
| 61408 | Scl23 | Serum cholesterol level QTL 23 | | 0.0005 | blood HDL phospholipid amount (VT:0010504) | serum high density lipoprotein phospholipid level (CMO:0001567) | 4 | 1 | 27716890 | Rat |
| 631209 | Bw2 | Body weight QTL2 | 4.2 | | retroperitoneal fat pad mass (VT:0010430) | retroperitoneal fat pad weight to body weight ratio (CMO:0000635) | 4 | 9940885 | 44463908 | Rat |
| 8694374 | Bw155 | Body weight QTL 155 | 3.39 | 0.001 | body lean mass (VT:0010483) | lean tissue morphological measurement (CMO:0002184) | 4 | 10084089 | 55084089 | Rat |
| 2303168 | Bp330 | Blood pressure QTL 330 | 4.25 | 0.017 | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 5214602 | 146446691 | Rat |
| 9589046 | Scfw2 | Subcutaneous fat weight QTL 2 | 5.54 | 0.001 | subcutaneous adipose mass (VT:1000472) | abdominal subcutaneous fat pad weight (CMO:0002069) | 4 | 1 | 31934116 | Rat |
| 6478724 | Anxrr35 | Anxiety related response QTL 35 | | 0.00449 | defecation behavior trait (VT:0010462) | defecation measurement (CMO:0000997) | 4 | 10084089 | 55084089 | Rat |
| 61351 | Bp33 | Blood pressure QTL 33 | | 0.0018 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 1 | 27716890 | Rat |
| 61415 | Eae11 | Experimental allergic encephalomyelitis QTL 11 | 2.9 | | nervous system integrity trait (VT:0010566) | post-insult time to onset of experimental autoimmune encephalomyelitis (CMO:0001422) | 4 | 1 | 39505420 | Rat |
| 1641905 | Colcr1 | Colorectal carcinoma resistance QTL 1 | 4.3 | 0.0003 | intestine integrity trait (VT:0010554) | benign colorectal tumor surface area measurement (CMO:0001799) | 4 | 1 | 29494328 | Rat |
| 619616 | Bp79 | Blood pressure QTL 79 | | 0.0292 | arterial blood pressure trait (VT:2000000) | systolic blood pressure (CMO:0000004) | 4 | 5214602 | 78882945 | Rat |
| 1358201 | Gluco12 | Glucose level QTL12 | 1.6 | | adipocyte glucose uptake trait (VT:0004185) | adipocyte maximal glucose uptake (CMO:0000870) | 4 | 5218392 | 29593287 | Rat |
| 738021 | Hcar13 | Hepatocarcinoma resistance QTL 13 | 4.3 | | liver integrity trait (VT:0010547) | liver nonremodeling tumorous lesion volume to total liver volume ratio (CMO:0001464) | 4 | 1 | 32584199 | Rat |
| 1358203 | Stl19 | Serum triglyceride level QTL 19 | 2.8 | 0.002 | blood triglyceride amount (VT:0002644) | serum triglyceride level (CMO:0000360) | 4 | 5218294 | 65958103 | Rat |
| 9590304 | Scort17 | Serum corticosterone level QTL 17 | 4.96 | 0.001 | blood corticosterone amount (VT:0005345) | plasma corticosterone level (CMO:0001173) | 4 | 10084089 | 55084089 | Rat |
| 9589097 | Slep11 | Serum leptin concentration QTL 11 | 5.09 | 0.001 | blood leptin amount (VT:0005667) | plasma leptin level (CMO:0000781) | 4 | 1 | 31934116 | Rat |
| 2316958 | Gluco58 | Glucose level QTL 58 | 10 | | blood glucose amount (VT:0000188) | blood glucose level (CMO:0000046) | 4 | 11320076 | 180699135 | Rat |
| 1300141 | Bp178 | Blood pressure QTL 178 | | | arterial blood pressure trait (VT:2000000) | mean arterial blood pressure (CMO:0000009) | 4 | 10024901 | 39524530 | Rat |
